Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F9W14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,034
Award facts
- Contract value 100% obligated
- $12,033.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,033.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 31, 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. NURTEC ODT (rimegepant) is a migraine treatment medication, consistent with the company's role in delivering neurological and pain management pharmaceuticals to support Defense Health Agency operations and military treatment facilities worldwide. This delivery order exemplifies the routine pharmaceutical procurement operations conducted through DLA's established prime vendor relationships, ensuring reliable supply chain access to essential medications for federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9W14?
SPE2DR26F9W14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9W14 worth?
The government has obligated $12,034 on SPE2DR26F9W14.
Is contract SPE2DR26F9W14 an order under another contract?
Yes. SPE2DR26F9W14 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W14 competed?
The extent of competition for SPE2DR26F9W14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award